Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study (2016)
- Authors:
- USP affiliated authors: FUKUI, ROSA TSUNECHIRO - FM ; ROCHA, DALVA MARREIRO - FM
- Unidade: FM
- DOI: 10.1186/s13098-015-0120-6
- Subjects: BIOMARCADORES; INFLAMAÇÃO; FÁRMACOS IMUNOSSUPRESSORES; METABOLISMO; DIABETES MELLITUS
- Language: Inglês
- Imprenta:
- Source:
- Título: Diabetology and Metabolic Syndrome
- ISSN: 1758-5996
- Volume/Número/Paginação/Ano: v. 8, art. 1, 9 p., 2016
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
TOSTES, Glauce Cordeiro Ulhôa et al. Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study. Diabetology and Metabolic Syndrome, v. 8, p. 9 , 2016Tradução . . Disponível em: http://dmsjournal.biomedcentral.com/articles/10.1186/s13098-015-0120-6. Acesso em: 02 out. 2024. -
APA
Tostes, G. C. U., Cunha, M. R., Fukui, R. T., Correia, M. R. S., Rocha, D. M., Santos, R. F. dos, & Silva, M. E. R. da. (2016). Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study. Diabetology and Metabolic Syndrome, 8, 9 . doi:10.1186/s13098-015-0120-6 -
NLM
Tostes GCU, Cunha MR, Fukui RT, Correia MRS, Rocha DM, Santos RF dos, Silva MER da. Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study [Internet]. Diabetology and Metabolic Syndrome. 2016 ; 8 9 .[citado 2024 out. 02 ] Available from: http://dmsjournal.biomedcentral.com/articles/10.1186/s13098-015-0120-6 -
Vancouver
Tostes GCU, Cunha MR, Fukui RT, Correia MRS, Rocha DM, Santos RF dos, Silva MER da. Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study [Internet]. Diabetology and Metabolic Syndrome. 2016 ; 8 9 .[citado 2024 out. 02 ] Available from: http://dmsjournal.biomedcentral.com/articles/10.1186/s13098-015-0120-6 - Insulin (IAA), glutamic acid decarboxylase-65 (antigad) and tyrosine-phosphatase (anti-IA2) autoantibodies: prevalence and association with hla-dr haplotypes, ins vntr, and ctla4 in siblings of patients with type 1 diabetes in Brazil
- Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment
- Auto-anticorpos não pancreáticos: prevalencia e associação com HLA-DR/DQ, alelos de classe I do VNTR e CTLA4 em diabetes tipo 1A em pacientes brasileiros
- Efeitos benéficos da associação de rosiglitazona ou metformina à glibenclamida no controle Glicêmico e risco cardiovascular
- Genetic Association of the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) and Type 1 Diabetes in Brazil
- Analisys of the distribuition of class I and II VNTR alleles of the insulin gene linked minisatellite locus in type 1 diabetes mellitus in Brazil
- Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study
- Insulin (IAA), Glutamic Acid Decarboxilase-65 (antiGAD) and Tirosine-Fosfatase (anti-IA2) Autoantibodies (AB): Prevalence and Associations with HLA-DR Haplotypes, Insulin VNTR and CTLA4 alleles in siblings of type i diabetes (DM1) Patients
- Non-Islet Autoantibodies (Non-IsletAAb): Prevalence and Association with PTPN22 1858T in Brazilian Type I Diabetes Mellitus (DMI) Patients
- Resposta terapêutica ao uso de rosiglitazona ou nateglinida em diabéticos do tipo 2.
Informações sobre o DOI: 10.1186/s13098-015-0120-6 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas